Researchers found that butyrate, a microbial metabolite, enhances T-cell activity, thereby boosting IgA antibody production. This pathway may be key in enhancing mucosal vaccine responses and offers a ...
A research team from POSTECH and ImmunoBiome in Korea, led by Professor Sin-Hyeog Im, has uncovered a new mechanism showing ...
We demonstrates an innovative strategy for mucosal vaccine design by integrating bacterial N-terminal fatty acylation into a ...
High levels of mucosal antibodies in the airways reduce the risk of being infected by omicron, but many do not receive detectable antibodies in the airways despite three doses of the SARS-CoV-2 ...
The induction of respiratory mucosal immunity, characterized by secretory IgA (sIgA) and lung-resident memory T (TRM) cells, is essential for ...
Mucosal barrier injury (MBI) occurs during periods of prolonged neutropenia in patients receiving cytotoxic chemotherapy for hematologic malignancies. This can lead to laboratory-confirmed bloodstream ...
For patients with gastroesophageal reflux disease (GERD), improvement in symptoms is seen with both antireflux mucosectomy (ARMS) and antireflux mucosal ablation (ARMA), but subjective and objective ...
A research team from Shenyang Agricultural University, led by Dr. Bin Li, has highlighted the potential of malvidin-3-O-galactoside (M3G), a blueberry-derived anthocyanin, to improve colonic mucosal ...
Researchers have developed an intranasal COVID-19 vaccine that enhances the immune system’s response to the virus, providing longer-lasting, greater protection than vaccine injections, even against ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Experts argued for the development of COVID-19 vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results